281 related articles for article (PubMed ID: 33296902)
1. Biosafety Requirements for Autopsies of Patients with COVID-19: Example of a BSL-3 Autopsy Facility Designed for Highly Pathogenic Agents.
Loibner M; Langner C; Regitnig P; Gorkiewicz G; Zatloukal K
Pathobiology; 2021; 88(1):37-45. PubMed ID: 33296902
[TBL] [Abstract][Full Text] [Related]
2. Biosafety level 3 laboratory for autopsies of patients with severe acute respiratory syndrome: principles, practices, and prospects.
Li L; Gu J; Shi X; Gong E; Li X; Shao H; Shi X; Jiang H; Gao X; Cheng D; Guo L; Wang H; Shi X; Wang P; Zhang Q; Shen B
Clin Infect Dis; 2005 Sep; 41(6):815-21. PubMed ID: 16107979
[TBL] [Abstract][Full Text] [Related]
3. Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future.
Hofman P; Ilié M; Chamorey E; Brest P; Schiappa R; Nakache V; Antoine M; Barberis M; Begueret H; Bibeau F; Bonnetaud C; Boström P; Brousset P; Bubendorf L; Carvalho L; Cathomas G; Cazes A; Chalabreysse L; Chenard MP; Copin MC; Côté JF; Damotte D; de Leval L; Delongova P; Thomas de Montpreville V; de Muret A; Dema A; Dietmaier W; Evert M; Fabre A; Forest F; Foulet A; Garcia S; Garcia-Martos M; Gibault L; Gorkiewicz G; Jonigk D; Gosney J; Hofman A; Kern I; Kerr K; Kossai M; Kriegsmann M; Lassalle S; Long-Mira E; Lupo A; Mamilos A; Matěj R; Meilleroux J; Ortiz-Villalón C; Panico L; Panizo A; Papotti M; Pauwels P; Pelosi G; Penault-Llorca F; Pop O; Poté N; Cajal SRY; Sabourin JC; Salmon I; Sajin M; Savic-Prince S; Schildhaus HU; Schirmacher P; Serre I; Shaw E; Sizaret D; Stenzinger A; Stojsic J; Thunnissen E; Timens W; Troncone G; Werlein C; Wolff H; Berthet JP; Benzaquen J; Marquette CH; Hofman V; Calabrese F
ESMO Open; 2021 Feb; 6(1):100024. PubMed ID: 33399086
[TBL] [Abstract][Full Text] [Related]
4. Biosafety measures for preventing infection from COVID-19 in clinical laboratories: IFCC Taskforce Recommendations.
Lippi G; Adeli K; Ferrari M; Horvath AR; Koch D; Sethi S; Wang CB
Clin Chem Lab Med; 2020 Jun; 58(7):1053-1062. PubMed ID: 32396137
[TBL] [Abstract][Full Text] [Related]
5. Design and Construction of a Biosafety Level 3 Autopsy Laboratory.
Nolte KB; Muller TB; Denmark AM; Burstein R; Villalobos YA
Arch Pathol Lab Med; 2021 Apr; 145(4):407-414. PubMed ID: 33307551
[TBL] [Abstract][Full Text] [Related]
6. Biorisk Management for SARS-CoV-2 Research in a Biosafety Level-3 Core Facility.
Joseph T; Phyu S; Se-Thoe SY; Chu JJH
Methods Mol Biol; 2022; 2452():441-464. PubMed ID: 35554920
[TBL] [Abstract][Full Text] [Related]
7. Biosafety and Biohazards: Understanding Biosafety Levels and Meeting Safety Requirements of a Biobank.
Ta L; Gosa L; Nathanson DA
Methods Mol Biol; 2019; 1897():213-225. PubMed ID: 30539447
[TBL] [Abstract][Full Text] [Related]
8. Biosafety threats of the rapidly established labs for SARS-CoV-2 tests in China.
Yuan D; Gao W; Liang S; Yang S; Jia P
Environ Int; 2020 Oct; 143():105964. PubMed ID: 32768807
[TBL] [Abstract][Full Text] [Related]
9. Minimally Invasive Tissue Sampling as an Alternative to Complete Diagnostic Autopsies in the Context of Epidemic Outbreaks and Pandemics: The Example of Coronavirus Disease 2019 (COVID-19).
Bassat Q; Varo R; Hurtado JC; Marimon L; Ferrando M; Ismail MR; Carrilho C; Fernandes F; Castro P; Maixenchs M; Rodrigo-Calvo MT; Guerrero J; Martínez A; Lacerda MVG; Mandomando I; Menéndez C; Martinez MJ; Ordi J; Rakislova N
Clin Infect Dis; 2021 Dec; 73(Suppl_5):S472-S479. PubMed ID: 34910176
[TBL] [Abstract][Full Text] [Related]
10. Challenges in the establishment of a biosafety testing laboratory for COVID-19 in Bangladesh.
Islam SRU; Akther T; Sultana S; Deb P; Ghosh AK; Nasif MAO; Bhuiyan AH; Jahan M; Nessa A; Munshi SU; Tabassum S
J Infect Dev Ctries; 2021 Dec; 15(12):1833-1837. PubMed ID: 35044940
[TBL] [Abstract][Full Text] [Related]
11. Retrospective Post-mortem SARS-CoV-2 RT-PCR of Autopsies with COVID-19-Suggestive Pathology Supports the Absence of Lethal Community Spread in Basel, Switzerland, before February 2020.
Haslbauer JD; Perrina V; Matter M; Dellas A; Mihatsch MJ; Tzankov A
Pathobiology; 2021; 88(1):95-105. PubMed ID: 33161409
[TBL] [Abstract][Full Text] [Related]
12. Laboratory Biosafety Considerations of SARS-CoV-2 at Biosafety Level 2.
Wang K; Zhu X; Xu J
Health Secur; 2020; 18(3):232-236. PubMed ID: 32522074
[TBL] [Abstract][Full Text] [Related]
13. Selection and application of biological safety cabinets in diagnostic and research laboratories with special emphasis on COVID-19.
Pawar SD; Khare AB; Keng SS; Kode SS; Tare DS; Singh DK; More RL; Mullick J
Rev Sci Instrum; 2021 Aug; 92(8):081401. PubMed ID: 34470433
[TBL] [Abstract][Full Text] [Related]
14. Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 1. Biosafety Level 4 Suit Laboratory Suite Entry and Exit Procedures.
Janosko K; Holbrook MR; Adams R; Barr J; Bollinger L; Newton JT; Ntiforo C; Coe L; Wada J; Pusl D; Jahrling PB; Kuhn JH; Lackemeyer MG
J Vis Exp; 2016 Oct; (116):. PubMed ID: 27768063
[TBL] [Abstract][Full Text] [Related]
15. Universal Precautions Provide Appropriate Protection during Autopsies of Patients with Infectious Diseases.
Kritselis M; Remick DG
Am J Pathol; 2020 Nov; 190(11):2180-2184. PubMed ID: 32827462
[TBL] [Abstract][Full Text] [Related]
16. The craniotomy box: an innovative method of containing hazardous aerosols generated during skull saw use in autopsy on a COVID-19 body.
Hasmi AH; Khoo LS; Koo ZP; Suriani MUA; Hamdan AN; Yaro SWM; Arshad S; Siew SF; Ibrahim MA; Mahmood MS
Forensic Sci Med Pathol; 2020 Sep; 16(3):477-480. PubMed ID: 32500339
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists.
Calabrese F; Pezzuto F; Fortarezza F; Hofman P; Kern I; Panizo A; von der Thüsen J; Timofeev S; Gorkiewicz G; Lunardi F
Virchows Arch; 2020 Sep; 477(3):359-372. PubMed ID: 32642842
[TBL] [Abstract][Full Text] [Related]
18. Procedures for Flow Cytometry-Based Sorting of Unfixed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Cells and Other Infectious Agents.
Reifel KM; Swan BK; Jellison ER; Ambrozak D; Baijer J; Nguyen R; Monard S; Lyon G; Fontes B; Perfetto SP
Cytometry A; 2020 Jul; 97(7):674-680. PubMed ID: 32488957
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 Autopsies: A Case Series from Poland.
Chmielik E; Jazowiecka-Rakus J; Dyduch G; Nasierowska-Guttmejer A; Michalowski L; Sochanik A; Ulatowska-Bialas M
Pathobiology; 2021; 88(1):78-87. PubMed ID: 33254171
[TBL] [Abstract][Full Text] [Related]
20. Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities.
Falasca L; Nardacci R; Colombo D; Lalle E; Di Caro A; Nicastri E; Antinori A; Petrosillo N; Marchioni L; Biava G; D'Offizi G; Palmieri F; Goletti D; Zumla A; Ippolito G; Piacentini M; Del Nonno F
J Infect Dis; 2020 Nov; 222(11):1807-1815. PubMed ID: 32914853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
